Myriad Genetics shareholders approve 4 million-share increase to employee stock purchase plan

• Myriad Genetics held its annual shareholder meeting on June 4, 2026.
• Shareholders ratified Ernst & Young as independent registered public accounting firm for the year ending Dec. 31, 2026.
• Investors adopted an amendment to the 2012 employee stock purchase plan, increasing the share pool by 4,000,000 shares.
• Shareholders adopted the 2026 equity incentive plan with 8,463,567 shares available, with potential increases up to 8,659,575 shares.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Myriad Genetics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0000899923-26-000059), on June 04, 2026, and is solely responsible for the information contained therein.